Seroprevalence for toxoplasmosis in individuals living in North West Tuscany: Access to Toxo-test in central Italy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 6, 2012, Pages 1151-1156

  Pinto, B ^a   Castagna, B ^a   Mattei, R ^b   Bruzzi, R ^c   Chiumiento, L ^a   Cristofani, R ^a   Buffolano, W ^d   Bruschi, F ^a  

^a UNIVERSITY OF PISA   (Italy)

^b ASL 2   (Italy)

^c Ospedale Civico di Carrara   (Italy)

^d FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PARASITE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; CHILD; ENZYME IMMUNOASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HIGH RISK PREGNANCY; HOSPITAL LABORATORY; HUMAN; INFANT; INFECTION RISK; ITALY; MALE; MATERNAL ATTITUDE; PRENATAL SCREENING; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEROPREVALENCE; SEX DIFFERENCE; TOXOPLASMOSIS; ARTICLE; BLOOD; EPIDEMIOLOGY; IMMUNOASSAY; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; NEWBORN; TOXOPLASMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; ITALY; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

EID: 84863831211     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1422-8     Document Type: Review

References (30)

1. Hill D, Dubey JP (2002) Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 8:634-640 (Pubitemid 35277118)
2. Remington JS, McLeod R, Thulliez P, Desmonts G (2001) Toxoplasmosis. In: Remington JS, Klein J (eds) Infectious diseases of the fetus and newborn infant, 5th edn. Saunders, Philadelphia, pp 205-346
3. Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, Peyron F (2004) Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113(6):1567-1572 (Pubitemid 38697960)
4. Owen WE, Martins TB, Litwin CM, Roberts WL (2006) Performance characteristics of six Immulite 2000 TORCH assays. Am J Clin Pathol 126:900-905 (Pubitemid 44901843)
5. Petersen E (2007) Toxoplasmosis. Semin Fetal Neonatal Med 12:214-223 (Pubitemid 46670815)
6. Villena I, Ancelle T, Delmas C, Garcia P, Brézin AP, Thulliez P, Wallon M, King L, Goulet V (2010) Congenital toxoplasmosis in France in 2007: first results from a National surveillance system. Eur Surveill 15(25)pii:19600
7. Montoya JG, Jordan R, Lingamneni S, Berry GJ, Remington JS (1997) Toxoplasmic myocarditis and polymyositis in patients with acute acquired toxoplasmosis diagnosed during life. Clin Infect Dis 24:676-683 (Pubitemid 27143563)
8. Paspalaki PK, Mihailidou EP, Bitsori M, Tsagkaraki D, Mantzouranis E (2001) Polyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl. BMC Musculoskelet Disord 2:8
9. Contini C (2008) Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Parassitologia 50(1-2):45-50
10. Hassene A, Vital A, Anghel A, Guez S, Series C (2008) Acute acquired toxoplasmosis presenting as polymyositis and chorioretinitis in immunocompetent patient. Jt Bone Spine 75(5):603- 605
11. Klaeger AJ, Herbort CP (2009) Acute acquired toxoplasmic retinochoroiditis in a patient with anterior uveitis, amplified by immunosuppressive therapy. Int Ophthalmol 29(3):191-193
12. Neves Ede S, Kropf A, Bueno WF, Bonna IC, Curi AL, Amendoeira MR, Filho OF (2011) Disseminated toxoplasmosis: an atypical presentation in an immunocompetent patient. Trop Doct 41(1):59-60
13. Evengård B, Petersson K, Engman ML, Wiklund S, Ivarsson SA, Teär-Fahnehjelm K, Forsgren M, Gilbert R, Malm G (2001) Low incidence of Toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 127(1):121-127 (Pubitemid 32825647)
14. Fan CK, Hung CC, Su KE, Chiou HY, Gil V, Ferreira Mda C, Tseng LF (2007) Seroprevalence of Toxoplasma gondii infection among inhabitants in the Democratic Republic of Sao Tome and Principe. Trans R Soc Trop Med Hyg 101(11):1157-1158 (Pubitemid 47454408)
15. Bouhamdan SF, Bitar LK, Saghir HJ, Bayan A, Araj GF (2010) Seroprevalence of toxoplasma antibodies among individuals tested at hospitals and private laboratories in Beirut. J Med Liban 58(1):8-11
16. Hofhuis A, van Pelt W, van Duynhoven YT, Nijhuis CD, Mollema L, van der Klis FR, Havelaar AH, Kortbeek LM (2010) Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiol Infect 24:1-9
17. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M (2007) Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg 77(3):405- 410 (Pubitemid 351844310)
18. Stricker R, Sitavanc R, Liassine N, de Marval F (2009) Toxoplasmosis during pregnancy and infancy. Swiss Med Wkly 139:643-644
19. De Paschale M, Agrappi C, Clerici P, Mirri P, Manco MT, Cavallari S, Viganò EF (2008) Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy. Clin Microbiol Infect 14(2):186-189
20. Bénard A, Petersen E, Salamon R, Chêne G, Salmi LR, European Toxo Prevention Study Group (EUROTOXO) (2008) Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Eur Surveill 13(15):1-13
21. Stagni L, Romano MA, Romano A, Magli A, Briganti F, Del Pezzo MA, Buffolano W (2009) Prenatal screening for congenital toxoplasmosis in Campania: preliminary report on activities and results. Mem Inst Oswaldo Cruz 104(2):374-377
22. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965-1976 (Pubitemid 38759657)
23. ARS Toscana (2006) Nascere in Toscana - Anni 2002-2004. Documenti ARS 21: 140; www.arsanita.toscana.it
24. Petersen E, Vesco G, Villari S, BuffolanoW(2010) What do we know about risk factors for infection in humans with Toxoplasma gondii and how can we prevent infections? Zoonoses Public Health 57:8-17
25. Valcavi PP, Natali A, Soliani L, Montali S, Dettori G, Chezzi C (1995) Prevalence of anti-Toxoplasma gondii antibodies in the population of the area of Parma (Italy). Eur J Epidemiol 11 (3):333-337
26. Vezzo R, Vigorè L, Goglio A, Raglio A, Vecchia L, Terenziani P, Fortina G et al (2001) Sieroprevalenza per anticorpi anti-Toxoplasma gondii in 14.186 soggetti. Microbiol Med 16:220
27. De Paschale M, Agrappi C, Clerici P, Mirri P, Manco MT, Cavallari S, Viganò EF (2006) Prevalence of Toxoplasma gondii infection in the Italian and foreign female population living in the area of Legnano (Milan). Microbiol Med 21:322-327
28. Condorelli F, Scalia G, Stivala A, Costanzo MC, Adragna AD, Franceschino C, Santagati MG, Furneri PM, Marino A, Castro A (1993) Seroprevalence to some TORCH agents in a Sicilian female population of fertile age. Eur J Epidemiol 9:341-343 (Pubitemid 23238064)
29. Castelli F, Tomasoni L, Caligaris S, Barberis D, Laddago V, Di Candilo F, Donato F (1995) Epidemiological aspects of congenital toxoplasmosis. Riv Parassitol 12:19-23
30. De Paschale M, Agrappi C, Manco MT, Cerulli T, Clerici P (2010) Implementation of screening for Toxoplasma gondii infection in pregnancy. J Clin Med Res 3:112-116